Flightless I Homolog Reverses Neo-Endocrine Therapy Resistance through YBX1/PD-L1 Axis Mediated-Immune Evasion in Prostate Cancer
Hailong Ruan(Union Hospital), Ke Chen(Huazhong University of Science and Technology)
Cited by 1
Related Papers
CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling
|Oncotarget|2014|66
Overexpression of SOX4 promotes cell migration and invasion of renal cell carcinoma by inducing epithelial-mesenchymal transition
|International Journal of Oncology|2017|46